Wells Fargo & Company Citius Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 50,842 shares of CTXR stock, worth $34,572. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,842

Previous 41,386 22.85%

Holding current value

$34,572

Previous $31,000 45.16%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.6 - $0.9 $5,673 - $8,510	9,456 Added 22.85%	50,842 $45,000
Q4 2023 Feb 09, 2024	BUY	$0.65 - $0.86 $4,847 - $6,413	7,458 Added 21.98%	41,386 $31,000
Q3 2023 Nov 13, 2023	SELL	$0.65 - $1.25 $11,406 - $21,935	-17,548 Reduced 34.09%	33,928 $23,000
Q2 2023 Aug 15, 2023	BUY	$1.08 - $1.65 $50,269 - $76,800	46,546 Added 944.14%	51,476 $61,000
Q1 2023 May 12, 2023	BUY	$0.78 - $1.42 $10 - $19	14 Added 0.28%	4,930 $5,000

Q4 2022 Feb 13, 2023	BUY	$0.79 - $1.23 $18 - $28	23 Added 0.47%	4,916 $3,000
Q3 2022 Nov 14, 2022	SELL	$0.14 - $1.33 $0 - $9	-7 Reduced 0.14%	4,893 $6,000
Q2 2022 Aug 12, 2022	SELL	$0.88 - $1.87 $21,843 - $46,417	-24,822 Reduced 83.51%	4,900 $5,000
Q1 2022 May 16, 2022	SELL	$1.38 - $1.89 $51,661 - $70,754	-37,436 Reduced 55.74%	29,722 $53,000
Q4 2021 Feb 14, 2022	SELL	$1.51 - $2.2 $877,977 - $1.28 Million	-581,442 Reduced 89.65%	67,158 $103,000
Q3 2021 Nov 15, 2021	BUY	$1.74 - $2.6 $1.12 Million - $1.67 Million	644,062 Added 14192.64%	648,600 $1.32 Million
Q2 2021 Aug 16, 2021	BUY	$1.51 - $4.23 $2,746 - $7,694	1,819 Added 66.9%	4,538 $15,000
Q1 2021 May 13, 2021	BUY	$1.04 - $2.34 $473 - $1,064	455 Added 20.1%	2,719 $5,000
Q4 2020 Feb 09, 2021	BUY	$0.9 - $1.2 $14 - $19	16 Added 0.71%	2,264 $2,000
Q3 2020 Nov 05, 2020	BUY	$0.83 - $1.51 $109 - $199	132 Added 6.24%	2,248 $2,000
Q2 2020 Aug 13, 2020	SELL	$0.65 - $1.45 $10,705 - $23,881	-16,470 Reduced 88.62%	2,116 $2,000
Q1 2020 May 14, 2020	BUY	$0.46 - $1.3 $8,549 - $24,161	18,586 New	18,586 $11,000

Others Institutions Holding CTXR

# of Institutions

Shares Held

26.8M

Call Options Held

Put Options Held

View Full List

About Citius Pharmaceuticals, Inc.

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $99.4M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

More about CTXR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Citius Pharmaceuticals, Inc. Transaction History